Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
The American Journal of Pathology|September 6, 2002
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiationRainer Kuefer, Sooryanarayana Varambally, Ming Zhou, et al.Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.Neuro-Oncology|July 6, 2011
Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formationNinel Azoitei, Alexander Kleger, Nina Schoo, et al.Frontiers in Oncology|January 9, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial DiagnosisMarie Christine Hupe, Christian Philippi, Doris Roth, et al.Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.Urologic Oncology|June 11, 2019
TRIM24 as an independent prognostic biomarker for prostate cancerAnne Offermann, Doris Roth, Marie Christine Hupe, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.Science (New York, N.Y.)|October 29, 2005
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancerScott A Tomlins, Daniel R Rhodes, Sven Perner, et al.Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.Pageof 6